We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$1.44M
Cap. Flow
-$1.6M
Cap. Flow %
-1.38%
Top 10 Hldgs %
24.2%
Holding
184
New
25
Increased
26
Reduced
81
Closed
25

Top Buys

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$1.1M
2
AZN icon
AstraZeneca
AZN
+$748K
3
NVS icon
Novartis
NVS
+$704K
4
AVT icon
Avnet
AVT
+$701K
5
SYNA icon
Synaptics
SYNA
+$698K

Top Sells

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$829K
2
TD icon
Toronto Dominion Bank
TD
+$755K
3
PVTB
PrivateBancorp Inc
PVTB
+$677K
4
BMY icon
Bristol-Myers Squibb
BMY
+$664K
5
WMT icon
Walmart Inc
WMT
+$646K

Sector Composition

Rank Sector Weight
1 Healthcare 19.02%
2 Industrials 16.07%
3 Consumer Staples 15.08%
4 Financials 12.64%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JWN
26
DELISTED
Nordstrom
JWN
$1.26M 1.09%
33,150
-900
-3% -$40K
ABT icon
27
Abbott
ABT
$184B
$1.22M 1.05%
31,027
+15,900
+105% +$633K
MMM icon
28
3M
MMM
$92.4B
$1.21M 1.04%
8,262
-239
-3% -$33.7K
TNL icon
29
Travel + Leisure Co
TNL
$4.68B
$1.19M 1.02%
36,935
-775
-2% -$24.8K
PB icon
30
Prosperity Bancshares
PB
$8.83B
$1.17M 1.01%
22,925
-550
-2% -$27.7K
ADI icon
31
Analog Devices
ADI
$190B
$1.13M 0.98%
20,000
-11,100
-36% -$636K
T icon
32
AT&T
T
$161B
$1.12M 0.96%
34,207
-993
-3% -$29.6K
EMR icon
33
Emerson Electric
EMR
$88B
$1.1M 0.95%
21,070
-1,200
-5% -$63.7K
INDB icon
34
Independent Bank
INDB
$3.98B
$1.1M 0.95%
24,028
-550
-2% -$25.7K
CSX icon
35
CSX Corp
CSX
$92.8B
$1.08M 0.93%
123,939
-150
-0.1% -$1.31K
PG icon
36
Procter & Gamble
PG
$337B
$1.04M 0.9%
12,280
-3,364
-22% -$276K
CVS icon
37
CVS Health
CVS
$122B
$1.02M 0.88%
10,685
+1,300
+14% +$130K
ABBV icon
38
AbbVie
ABBV
$428B
$960K 0.83%
15,508
-3,100
-17% -$189K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.12T
$894K 0.77%
6,173
-300
-5% -$42.9K
IBM icon
40
IBM
IBM
$220B
$839K 0.72%
5,779
-105
-2% -$15K
AKAM icon
41
Akamai
AKAM
$17.4B
$834K 0.72%
14,905
-200
-1% -$10.5K
UNP icon
42
Union Pacific
UNP
$173B
$832K 0.72%
9,538
-650
-6% -$55K
URI icon
43
United Rentals
URI
$72.7B
$810K 0.7%
12,075
-2,925
-20% -$191K
AZN icon
44
AstraZeneca
AZN
$250B
$777K 0.67%
+12,875
New +$748K
SLB icon
45
SLB Ltd
SLB
$76.3B
$755K 0.65%
9,552
-50
-0.5% -$3.83K
LEN icon
46
Lennar Class A
LEN
$20.6B
$754K 0.65%
17,177
+11,136
+184% +$487K
NVS icon
47
Novartis
NVS
$296B
$753K 0.65%
+10,188
New +$704K
RTX icon
48
RTX Corp
RTX
$298B
$725K 0.62%
11,234
-1,271
-10% -$81.3K
ELV icon
49
Elevance Health
ELV
$84.4B
$716K 0.62%
5,450
-50
-0.9% -$6.84K
DEO icon
50
Diageo
DEO
$53.5B
$711K 0.61%
6,300
-200
-3% -$21.6K
1
2
3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM

New England Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, New England Research & Management held 184 positions worth $116M, down 1.2% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q2 2016 filing shows 25 new, 26 increased, 81 reduced and 25 closed positions. Its largest new stake was AstraZeneca: 12,875 shares worth $777K. The largest sale was Martin Marietta Materials, an estimated $829K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q2 2016 buy was AstraZeneca: 12,875 shares worth $777K.
  • New England Research & Management added most to Valero Energy in Q2 2016, an estimated $1.1M increase.
  • New England Research & Management's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • New England Research & Management fully exited Martin Marietta Materials in Q2 2016, selling an estimated $829K.
  • New England Research & Management's ten largest holdings make up 24% of its $116M portfolio in Q2 2016.
  • New England Research & Management opened 25 new positions and closed 25 in Q2 2016.
  • New England Research & Management's portfolio value fell 1.2% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.